Irritable Bowel Syndrome (IBS) and Fibromyalgia
Irritable bowel syndrome (IBS) and fibromyalgia frequently travel together. IBS is a functional gastrointestinal disorder marked by abdominal pain with altered bowel habits, while fibromyalgia is a chronic pain condition characterized by widespread musculoskeletal pain, fatigue, and sleep disturbance. Understanding how they connect can improve diagnosis and management and reduce fragmented care. Consult your healthcare provider before making changes to your health regimen. Epidemiology and comorbidity data indicate meaningful overlap: IBS affects roughly 4–10% of people globally and fibromyalgia about 2–4%. Studies and guidelines report that 30–60% of people with fibromyalgia meet criteria for IBS, and 12–30% of those with IBS also have fibromyalgia. Shared risk factors include female sex and hormonal influences, chronic stress and anxiety, early-life adversity or trauma, poor sleep, and possibly post-infectious changes after gastroenteritis. These factors can amplify pain signaling and autonomic arousal, predisposing to both conditions. Several shared mechanisms help explain the overlap. Central sensitization—an amplified response of the nervous system to sensory input—drives both visceral hypersensitivity in IBS and widespread pain in fibromyalgia. Dysregulation of the autonomic nervous system and hypothalamic–pituitary–adrenal (HPA) axis links symptoms like bowel irregularity, palpitations, and heightened pain. Low-grade immune activation, including mast-cell and cytokine signaling in the gut, and altered intestinal permeability may feed into systemic symptoms. The gut–brain axis and microbiome appear important: IBS is a prototypical gut–brain disorder, and early studies suggest distinct microbiome signatures in fibromyalgia, supporting biologic crosstalk between gut and nervous system. Symptoms often overlap—pain, fatigue, sleep disturbance, brain fog, anxiety/depression, and in IBS, bowel symptoms such as diarrhea, constipation, bloating, and urgency. Co-occ
Updated April 10, 2026This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.
Shared Risk Factors
Female sex and hormonal influences
Moderate EvidenceWomen are disproportionately affected by both IBS and fibromyalgia, suggesting roles for sex hormones, pain modulation, and healthcare-seeking patterns.
Chronic stress, anxiety, and HPA axis dysregulation
Strong EvidenceStress and anxiety heighten autonomic arousal and alter cortisol patterns, contributing to pain amplification and bowel dysregulation.
Early-life adversity/trauma
Moderate EvidenceAdverse childhood experiences are associated with functional GI disorders and chronic widespread pain, possibly via central sensitization and stress-system imprinting.
Sleep disturbance
Moderate EvidenceNonrestorative sleep and insomnia lower pain thresholds and worsen fatigue and cognitive symptoms; sleep disruption can also alter GI motility and sensitivity.
Post-infectious and immune activation
Moderate EvidenceIBS frequently follows acute gastroenteritis; infections and immune changes can trigger long-lasting neural and gut dysfunction. Some cases of fibromyalgia follow infections.
Physical inactivity and deconditioning
Emerging ResearchReduced activity can worsen autonomic balance, sleep, and pain sensitivity, creating a feedback loop of symptoms.
Comorbidity Data
Prevalence
IBS affects ~4–10% and fibromyalgia ~2–4% of the general population. Among fibromyalgia patients, 30–60% meet criteria for IBS; among IBS patients, 12–30% meet criteria for fibromyalgia.
Mechanistic Link
Shared nociplastic pain mechanisms (central sensitization), autonomic/HPA-axis dysregulation, low-grade immune signaling, and gut–brain–microbiome interactions contribute to symptom clusters in both conditions.
Clinical Implications
Coexistence is associated with greater pain severity, more fatigue, poorer sleep, higher psychological distress, and increased healthcare use. Screening for the comorbid condition can clarify treatment options (e.g., neuromodulators, mind–body therapies) and reduce polypharmacy. Alarm features should still prompt targeted evaluation to avoid missed organic disease.
Sources (4)
- Sperber AD et al. Gastroenterology. 2021;160:99–114.e3.
- Lacy BE et al. Am J Gastroenterol. 2021;116:17–44.
- Clauw DJ. JAMA. 2014;311:1547–1555.
- Häuser W et al. Nat Rev Dis Primers. 2015;1:15022.
Overlapping Treatments
Low-dose tricyclic antidepressants (e.g., amitriptyline, nortriptyline)
Strong EvidenceReduce abdominal pain and improve global IBS symptoms via neuromodulation of visceral pain.
May lessen chronic widespread pain and improve sleep in fibromyalgia.
Anticholinergic effects (dry mouth, sedation); can worsen constipation—may suit IBS-D more than IBS-C.
SNRIs (e.g., duloxetine, milnacipran)
Moderate EvidenceSmall studies suggest improvement in global IBS symptoms and pain via central pain modulation.
Reduce pain and improve function in fibromyalgia; guideline-supported.
Nausea, sweating, insomnia possible; monitor blood pressure and interactions.
Gabapentinoids (pregabalin, gabapentin)
Moderate EvidenceDecrease rectal/visceral hypersensitivity and pain in IBS in small RCTs.
Improve pain and sleep in fibromyalgia in multiple RCTs.
Dizziness, edema, weight gain; misuse potential—use with caution and monitoring.
Aerobic and strengthening exercise (graded)
Moderate EvidenceImproves IBS symptom severity and quality of life; may modulate stress and motility.
One of the most effective nonpharmacologic options for fibromyalgia to reduce pain and fatigue.
Start low and progress gradually to avoid flares; tailor to tolerance.
Cognitive behavioral therapy (including gut-directed CBT) and gut-directed hypnotherapy
Strong EvidenceStrong evidence for reducing IBS pain and global symptoms via gut–brain retraining.
Improves coping, pain interference, and mood in fibromyalgia.
Access and cost can be barriers; digital programs may expand availability.
Mindfulness-based stress reduction, yoga, tai chi
Moderate EvidenceReduces stress reactivity and may improve IBS symptom scores.
Improves pain, sleep, and function in fibromyalgia; tai chi has RCT support.
Consistency matters; choose gentle forms initially.
Sleep optimization (CBT-I, regular schedules, treating comorbid sleep disorders)
Moderate EvidenceBetter sleep is associated with reduced abdominal pain and urgency.
Improves pain thresholds and daytime fatigue in fibromyalgia.
Consider evaluation for sleep apnea or limb movement disorders when indicated.
Dietary strategies (e.g., low-FODMAP for IBS; anti-inflammatory/Mediterranean patterns)
Strong EvidenceLow-FODMAP diet reduces bloating and pain in many with IBS; Mediterranean pattern supports gut health.
Anti-inflammatory patterns may reduce pain and fatigue; indirect benefits via improved gut symptoms when IBS coexists.
Low-FODMAP should be time-limited with reintroduction under dietitian guidance to protect nutritional adequacy and microbiome diversity.
Medical Perspectives
Two Ways of Seeing Health
Western
scientific · clinical
Western medicine applies science, technology, and clinical experience to treat symptoms through testing, diagnosis, and targeted intervention.
Surgeons · Pharmaceuticals · Clinical trials · Diagnostics 
Eastern
traditional · alternative
Eastern medicine focuses on treating the body naturally by applying traditional knowledge practiced for thousands of years, emphasizing balance and whole-person wellness.
Acupuncture · Herbal medicine · Yoga · Meditation
Gold Bamboo presents both perspectives side-by-side so you can make informed decisions. We don't advocate for one over the other — your health choices are yours.
Two Ways of Seeing Health
Western
scientific · clinical
Western medicine applies science, technology, and clinical experience to treat symptoms through testing, diagnosis, and targeted intervention.
Eastern
traditional · alternative
Eastern medicine focuses on treating the body naturally by applying traditional knowledge practiced for thousands of years, emphasizing balance and whole-person wellness.
Gold Bamboo presents both perspectives side-by-side so you can make informed decisions. We don't advocate for one over the other — your health choices are yours.
Western Perspective
Western medicine increasingly views IBS and fibromyalgia as overlapping ‘nociplastic’ disorders involving central sensitization, dysregulated gut–brain and stress pathways, and low-grade immune signaling. Co-occurrence is common and portends higher symptom burden, warranting integrated, multimodal care.
Key Insights
- Comorbidity rates are high: roughly one-third to over half of fibromyalgia patients meet IBS criteria; a meaningful minority of IBS patients meet fibromyalgia criteria.
- Central sensitization underlies visceral and widespread pain, with autonomic and HPA-axis dysregulation contributing to arousal and symptom flares.
- IBS shows mucosal immune activation and altered permeability; fibromyalgia shows autonomic changes and, in some studies, small fiber neuropathy—together suggesting systemic-biologic links.
- Neuromodulators (TCAs, SNRIs, gabapentinoids) and behavioral therapies (CBT, hypnotherapy) have cross-condition benefits.
- Alarm features still require targeted evaluation to avoid missing organic disease (e.g., IBD, celiac, rheumatologic disorders).
Treatments
- Neuromodulators: TCAs, SNRIs, gabapentinoids
- Psychological therapies: CBT, gut-directed hypnotherapy
- Lifestyle: graded exercise, sleep therapy
- Diet: low-FODMAP (IBS), Mediterranean/anti-inflammatory patterns
- Avoid or minimize opioids; consider multidisciplinary pain and GI care
Deep Dive
IBS and fibromyalgia are now understood as related disorders within the spectrum of nociplastic or central sensitivity syndromes. Epidemiologica... IBS and fibromyalgia are now understood as related disorders within the spectrum of nociplastic or central sensitivity syndromes. Epidemiologically, they overlap far beyond chance: about one-third to over half of individuals with fibromyalgia meet IBS criteria, and a meaningful minority of people with IBS have fibromyalgia. This co-occurrence reflects shared biology. Central sensitization lowers thresholds for pain across organ systems; in IBS this manifests as visceral hypersensitivity and altered motility, while in fibromyalgia it produces widespread musculoskeletal pain and allodynia. Dysregulation of the autonomic nervous system and hypothalamic–pituitary–adrenal axis further contributes to hyperarousal, sleep disturbance, and symptom flares. Low-grade immune activation, including mast cell signaling and subtle mucosal inflammation in IBS, may augment neural excitability. Microbiome alterations are well documented in IBS and have been reported in fibromyalgia, reinforcing gut–brain connections. Clinically, the symptom overlap—abdominal pain, bowel irregularity, fatigue, sleep disturbance, brain fog, and mood symptoms—complicates diagnosis and treatment. Western guidelines emphasize positive diagnostic criteria for IBS and fibromyalgia while remaining vigilant for red flags such as GI bleeding, unintended weight loss, anemia, onset after age 50, progressive focal neurologic deficits, or synovitis suggestive of inflammatory disease. When both diagnoses are present, outcomes are typically worse, healthcare use is higher, and the risk of polypharmacy rises. Treatment strategies with cross-condition benefit are prioritized. Neuromodulators including tricyclic antidepressants, SNRIs, and gabapentinoids can downregulate amplified pain signaling and improve sleep. Psychological therapies—particularly CBT and gut-directed hypnotherapy—are strongly supported for IBS and beneficial for fibromyalgia. Graded aerobic and strengthening exercise, along with sleep optimization and treatment of comorbid sleep disorders, address core drivers of sensitization. Diet is central for IBS, with low-FODMAP approaches reducing pain and bloating; Mediterranean-style patterns may help systemic inflammation and comorbid symptoms. Opioids are generally discouraged due to limited efficacy for nociplastic pain and risk of harm. Multidisciplinary coordination among gastroenterology, pain/rheumatology, behavioral health, sleep medicine, and nutrition can improve outcomes, especially for refractory or high-burden cases.
Sources
- Lacy BE et al. Am J Gastroenterol. 2021;116:17–44.
- Clauw DJ. JAMA. 2014;311:1547–1555.
- Black CJ, Ford AC. Nat Rev Gastroenterol Hepatol. 2020;17:473–486.
- Ford AC et al. Am J Gastroenterol. 2019;114:21–39.
- Macfarlane GJ et al. Ann Rheum Dis. 2017;76:318–328.
Eastern Perspective
Traditional systems frame these conditions as imbalances in vital energy and organ systems that regulate digestion, circulation, and the mind. In Traditional Chinese Medicine (TCM), IBS often reflects Liver–Spleen disharmony with Qi stagnation and dampness, while fibromyalgia resembles Bi syndrome or Qi/Blood stagnation with Spleen deficiency. Ayurveda associates IBS with Grahani (Agni/digestive fire dysregulation) and Vata-Pitta imbalance, and fibromyalgia with Vata aggravation affecting mamsa (muscle) and majja (nervous) tissues. Interventions aim to restore flow, calm the nervous system, harmonize digestion, and improve sleep—aligning with modern concepts of autonomic balance and mind–body integration.
Key Insights
- Acupuncture and acupressure modulate autonomic tone and endogenous opioids, showing short-term benefits in fibromyalgia and possible benefit in IBS.
- Herbal formulas that soothe Liver Qi and strengthen Spleen (e.g., Tong Xie Yao Fang, Xiao Yao San variants) are used for IBS patterns; some trials suggest symptom improvement.
- Mind–body practices (qigong, tai chi, yoga, meditation) cultivate relaxation, gentle movement, and breath, which can reduce pain perception and bowel reactivity.
- Dietary guidance emphasizes warm, easily digestible foods and routine; Ayurvedic approaches add individualized spices and routines to calm Vata and support Agni.
Treatments
- Acupuncture or electroacupuncture
- TCM herbal formulas (e.g., Tong Xie Yao Fang for IBS-D) under qualified supervision
- Yoga, tai chi, and qigong
- Breathwork and meditation; Ayurvedic dinacharya (daily routines)
- Abdominal moxibustion (selected IBS patterns)
Deep Dive
Traditional medicine frameworks describe IBS and fibromyalgia as systemic imbalances affecting digestion, circulation, and the mind–body interfa... Traditional medicine frameworks describe IBS and fibromyalgia as systemic imbalances affecting digestion, circulation, and the mind–body interface. In Traditional Chinese Medicine, IBS often reflects Liver Qi stagnation disturbing Spleen transport and transformation, leading to pain, bloating, and irregular stools; fibromyalgia may represent Bi syndrome with Qi and Blood stagnation and Spleen deficiency manifesting as widespread aching, fatigue, and heaviness. Treatment aims to restore harmonious flow, calm the shen (spirit), and strengthen the Spleen. Acupuncture and electroacupuncture are used to regulate autonomic tone and relieve pain; clinical trials show short-term benefit for fibromyalgia and variable but sometimes meaningful improvements in IBS when compared with usual care. Herbal formulas are tailored to pattern: Tong Xie Yao Fang is frequently used for IBS with diarrhea and abdominal cramping, while Xiao Yao San derivatives may address stress-related flares; oversight by qualified practitioners is important for safety and herb–drug interactions. Ayurveda situates IBS within Grahani—a disorder of Agni (digestive fire) and Vata-Pitta derangement—while fibromyalgia is seen as Vata aggravation affecting muscle and nervous tissues. Therapies emphasize regular routines (dinacharya), warm easily digestible foods, spices that support Agni (like ginger and cumin), gentle oil massage (abhyanga), breathwork (pranayama), meditation, and yoga. Mind–body practices, including tai chi, qigong, and yoga, cultivate parasympathetic dominance and mindful movement, which can ease pain and bowel reactivity; modern trials support tai chi in fibromyalgia and suggest benefit of yoga and mindfulness for IBS. These traditional views align with contemporary concepts of gut–brain axis regulation and autonomic balance. By addressing stress, sleep, diet, and gentle movement, they offer integrative strategies that complement biomedical care. For many, a combined approach—neuromodulatory pharmacotherapy where appropriate, evidence-based behavioral therapies, nutritional guidance, and selected traditional practices—can reduce symptom burden while honoring individual preferences and cultural context.
Sources
- Deare JC et al. Cochrane Database Syst Rev. 2013;CD007070.
- Manheimer E et al. Cochrane Database Syst Rev. 2012;CD005111.
- Wang C et al. N Engl J Med. 2010;363:743–754.
- Zhang J et al. Medicine (Baltimore). 2020;99:e20177 (Tong Xie Yao Fang meta-analysis).
- Palsson OS et al. Aliment Pharmacol Ther. 2015;41:1248–1265.
Evidence Ratings
Low-dose tricyclic antidepressants improve global IBS symptoms and abdominal pain.
Ford AC et al. Am J Gastroenterol. 2019;114:21–39.
A substantial proportion of patients with fibromyalgia meet criteria for IBS, indicating significant comorbidity.
Clauw DJ. JAMA. 2014;311:1547–1555.
Central sensitization contributes to both visceral hypersensitivity in IBS and widespread pain in fibromyalgia.
Black CJ, Ford AC. Nat Rev Gastroenterol Hepatol. 2020;17:473–486.
Pregabalin reduces visceral pain sensitivity in IBS in small randomized trials.
Houghton LA et al. Gastroenterology. 2007;133:108–115 (rectal mechanosensitivity study).
Gut-directed hypnotherapy and CBT improve IBS symptoms and quality of life.
Palsson OS et al. Aliment Pharmacol Ther. 2015;41:1248–1265.
Tai chi improves pain and function in fibromyalgia.
Wang C et al. N Engl J Med. 2010;363:743–754.
Fibromyalgia is associated with distinct gut microbiome signatures compared with healthy controls.
Minerbi A et al. Pain. 2019;160:2589–2602.
Acupuncture provides short-term pain relief in fibromyalgia; effects for IBS relative to sham are uncertain.
Deare JC et al. Cochrane 2013; Manheimer E et al. Cochrane 2012.
Sources
- Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide Prevalence and Burden of Irritable Bowel Syndrome: Results of the Rome Foundation Global Study. Gastroenterology. 2021;160(1):99–114.e3.
- Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021;116(1):17–44.
- Clauw DJ. Fibromyalgia: A Clinical Review. JAMA. 2014;311(15):1547–1555.
- Häuser W, Ablin JN, Buskila D, et al. Fibromyalgia. Nat Rev Dis Primers. 2015;1:15022.
- Black CJ, Ford AC. Global burden and pathophysiology of IBS. Nat Rev Gastroenterol Hepatol. 2020;17:473–486.
- Ford AC, Lacy BE, Harris LA, Quigley EMM, Moayyedi P. Effect of Antidepressants and Psychological Therapies in IBS: An Updated Systematic Review and Meta-analysis. Am J Gastroenterol. 2019;114(1):21–39.
- Houghton LA, et al. The Effect of Pregabalin on Visceral Sensation and Symptoms in IBS. Gastroenterology. 2007;133:108–115.
- Palsson OS, Whitehead WE, et al. Hypnosis and CBT for IBS: Systematic Review. Aliment Pharmacol Ther. 2015;41(12):1248–1265.
- Deare JC, Zheng Z, Xue CC, et al. Acupuncture for Treating Fibromyalgia. Cochrane Database Syst Rev. 2013;(5):CD007070.
- Manheimer E, Cheng K, Linde K, et al. Acupuncture for IBS. Cochrane Database Syst Rev. 2012;(5):CD005111.
- Wang C, Schmid CH, Rones R, et al. A Randomized Trial of Tai Chi for Fibromyalgia. N Engl J Med. 2010;363:743–754.
- Minerbi A, Gonzalez E, Brereton NJB, et al. Altered Microbiome Composition in Fibromyalgia. Pain. 2019;160(11):2589–2602.
- Barbara G, Stanghellini V, De Giorgio R, et al. Activated Mast Cells in Proximity to Colonic Nerves Correlate with Abdominal Pain in IBS. Gastroenterology. 2004;126(3):693–702.
- Johannesson E, Ringström G, Abrahamsson H, Sadik R. Intervention to Increase Physical Activity in IBS Shows Beneficial Effects. Am J Gastroenterol. 2011;106:915–922.
- Alammar N, Wang L, Saberi B, et al. Peppermint Oil for IBS: Systematic Review and Meta-analysis. BMC Complement Altern Med. 2019;19:21.
- Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR Revised Recommendations for the Management of Fibromyalgia. Ann Rheum Dis. 2017;76:318–328.
- Videlock EJ, et al. Child Abuse Is Associated with Functional GI Disorders in Adulthood. Clin Gastroenterol Hepatol. 2009;7(4):509–516.
Related Topics
Recommended Products
The FibroManual: A Complete Fibromyalgia Treatment Guide for You and Your Doctor: Liptan, Ginevra
In this unique resource, Ginevra Liptan, M.D., <strong>shares a cutting-edge new approach that goes far beyond mainstream medical knowledge to produce dramatic symptom improvement</strong>. Dr. Liptan
IBgard Gut Health Supplement, Peppermint Oil Capsules for Abdominal Comfort, 48 Capsules
DAILY GUT-HEALTH GARD (1): IBgard can be taken daily and is clinically shown to help manage a combination of occasional symptoms: cramping, bowel urgency, diarrhea, constipation, bloating, and gas (1)
THORNE - Magnesium Bisglycinate - Powdered Magnesium Formula - Supports Restful Sleep, Muscle Relaxation, Heart Health & Metabolism* - NSF Certified for Sport - Gluten, Dairy & Soy-Free - 60 Servings
THORNE - Magnesium Glycinate - <strong>Supports Restful Sleep, Muscle Relaxation, Heart Health & Metabolism</strong>* - Chelated Magnesium Capsules - Third-Party Certified - Gluten, Dairy & So
Health Disclaimer
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.